Project Grant K76AG083308
Award Date
8/23/24
Completion Date
5/31/29
Dollars Obligated
$243K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94158, USA
Similar Awards
This $1,230,000 Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) will support the development and deployment of closed-loop digital interventions through a remote clinical trials platform. The overarching goal is to leverage technology to facilitate memory and cognitive function and prevent or delay age-related cognitive decline, particularly in older adults at risk of Alzheimer's disease and related dementias. The...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) is providing $2,331,210 to the University of Maryland, Baltimore to develop novel analytical methods to better understand and predict post-fracture recovery trajectories in older adults living with Alzheimer's disease and related dementias (ADRD). The key products and services to be delivered include: Novel machine learning-assisted methods to identify unique patient characteristics...
This Project Grant award from the National Institute on Aging (Aging Research, CFDA 93.866) supports a $7,997,945 initiative to improve the diagnosis of Alzheimer's disease and related dementias in primary care settings. The project, led by the University of California, San Francisco, aims to demonstrate that a comprehensive diagnostic toolkit, combined with expert-led case conferences, can help primary care providers accurately distinguish mild cognitive impairment and Alzheimer's-related...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $663,376 to The Regents of the University of California, San Francisco to explore the molecular mechanisms underlying the heterogeneity of Alzheimer's disease and related dementias. The project aims to identify key genes that mediate the selective vulnerability of brain regions to distinct pathological protein conformers, such as tau and alpha-synuclein, using a novel computational modeling...
The National Institute on Aging awarded a $1,198,947 Project Grant under the Aging Research program (CFDA 93.866) to The Regents of the University of California, San Francisco (UCSF) on September 30, 2023. The grant will fund research to investigate the neuroprotective effects of a blood-derived enzyme called GPLD1 on Alzheimer's disease pathology. Specifically, the project aims to: 1) examine the relationships between GPLD1, physical activity, immunovascular function, and cognition in older...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $1,123,127 to the University of California, San Francisco (UCSF) to conduct research on optimizing medication use and support among people with dementia who live alone. The key objectives are to: Evaluate medication use and medication management supports among people with dementia who live alone using national survey and Medicare claims data. Conduct qualitative interviews to understand...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This Project Grant award of $309,550.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a study to develop and apply a novel "physical activity (PA) complexity" metric using accelerometer data to explore associations between PA patterns, cognitive function, and risk of Alzheimer's disease and related dementias (ADRD) in an older adult population. The key objectives are to: (1) examine the links between PA complexity, cognitive performance, and risk of...
This Project Grant award of $372,690 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to discover the heterogeneous causal pathophysiology of Alzheimer's disease (AD). The project will develop new statistical methods to uncover how amyloid-beta, tau accumulation, and cognition are causally related in different AD subpopulations. The goal is to reveal optimal treatment windows and target groups for therapies that reduce amyloid-beta or...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) for $791,086 aims to develop computational models that can predict the presence of non-Alzheimer's disease neuropathological changes, such as Lewy body disease, TDP-43 proteinopathy, and cerebral amyloid angiopathy, in individuals with Alzheimer's disease neuropathological changes. The project will leverage data from autopsy-confirmed datasets, in vivo neuroimaging, and clinical assessments to build...